Still, Witty said Glaxo believes it can meet demand.
The company is also expecting an increase in sales of Relenza, an existing antiviral treatment being used to combat swine flu. Second-quarter Relenza sales leapt to GBP60 million from GBP3 million a year earlier, Glaxo said Wednesday, as governments built stockpiles.
The company said it will triple its capacity to produce Relenza to 190 million doses annually by the end of the year.
!!!!!One hundred and sixty sacked Glaxo workers were recalled in France to help with this new effort, according to a report by Agence France Presse Wednesday !!!!!!!
As french labor laws are very difficult I belive in the expected sales .
BTA Price at posting:
$1.62 Sentiment: Hold Disclosure: Held
